Meanwhile, Shaker et al. (2019) suggest that lnc-DC can be used as a biomarker for the diagnosis of multiple sclerosis (MS) since they observed a high level of lnc-DC in the serum of patients with MS. Here, DCX is linked to myeloid sarcoma.